: iStockAnalyst.com Symbols Feed

FDA Calendar Updates: MELA, PGNX, VPHM, WYE, NeurogesX, Thoratec

Thu, 06 Aug 2009 15:24:00 GMT

Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 288 entries as of 8/5/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, ANDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete (...)[More...]

Thoratec (NasdaqGS: THOR) Executing Well In The Healthcare Space

Fri, 08 May 2009 11:58:46 GMT

Thoratec (NasdaqGS: THOR) was out with a nice report yesterday after the bell.[More...]

Sequenom (Nasdaq: SQNM) Bombshell

Wed, 29 Apr 2009 22:23:00 GMT

I am saying "wow" a lot of late - Sequenom (SQNM) is out with something after hours I've never seen in all the years I've been doing stocks; a delay in their Down Syndrome test due to employee mishandling of data. The stock is down 50% after hours. Worse - this was our only long position I actually have a hedge against, but I covered it into the weakness early this week - basically have 50 shares short as a holding position. On the long side we only have a 1.4% stake since the stock chart has been awful but looks like that will be 0.7% by tomorrow. Not good - it's one thing to be hit by an earnings situation but this is out of left field. Here I thought this was my personal Dendreon (DNDN) - something I'd stick with in the long run, waiting for the magical day to arrive it goes up 200% in a session. Well, we will see what[More...]

RVs Losing Speed

Mon, 27 Apr 2009 13:23:11 GMT

Makers of big-ticket items and luxury goods suffer the most during times like these, as consumers delay large purchases and reduce their expenses. Companies that recognize that they are in cyclical industries can put themselves in positions to outlast downturns and thereby emerge from them with fewer competitors. Nowhere is this more apparent than in the RV business, where sales have seemingly dropped off a cliff. Here are the[More...]

FDA, Clinical Trial Calendar Updates: THOR, ALTH

Tue, 21 Apr 2009 19:32:00 GMT

The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates...[More...]

Thoratec (THOR) Beats; Market Yawns

Fri, 06 Feb 2009 20:33:00 GMT

A rotation day is afoot; strange to see some of the old winners just sit flat on their back as the China/tech/commodities trade if on. Almost as if there is not enough money to push everything up at once. We are now back to the top of the "range" - if we get north of S&P 880 we'll consider this a more bullish scenario. We are setting up for a sell the news reaction to Monday's "this is how we are going to save the world" announcements by government. Thoratec (THOR) reported a nice beat last night but the stock is moribund. Heart device maker Thoratec Corp. said its profit jumped 73 percent in the fiscal fourth quarter due to strong sales of its HeartMate II pump. Late Thursday, Thoratec said its [More...]

Green names in a Sea of Red

Tue, 20 Jan 2009 18:20:00 GMT

Note - the action is so bad I will consider less than 1% loss "green" Here are some names of interest or current holdings holding up in this horror show **************** Insituform Technologies (INSU): "sewer" repair; been watching this for a month to add to the portfolio - it has Obama written all over it. Great chart - this one gapped up today on big volume; tells me an institution piled in or some good news is on the way. Airlines in general: weak oil = good for airlines Research in Motion (RIMM): really holding up well last week or two Palm (PALM): unrelenting (short squeeze) ([More...]

A New Global Healthcare Composite Index

Tue, 13 Jan 2009 14:16:00 GMT

The accompanying table (click to enlarge) presents the top five rated companies with market caps of at least $100M from each of the eight new ETF Innovators healthcare indexes, including a database exceeding 500 companies worldwide. The Healthcare Composite Index is a dynamic, semi-active index with quarterly rebalancing which consists of the 40 top-rated companies on an equal weight basis from each of the eight global healthcare indexes listed below and represents an alternative strategy to existing[More...]

Playbook For The Week

Mon, 12 Jan 2009 04:23:00 GMT

Now that the market has lightened up a bit on the "student body left" (or right) trading ("sell everything! buy everything!") we can spend some more time sorting out good charts from bad. Except in times of extremes - this is a market of stocks, not a stock market. Below I'll break out some of the stocks that we made some changes to last week, and others of interest with commentary.... 1) We had been holding off on adding to Emergent BioSolutions (EBS) as noted Thursday waiting to see if it was reading to break up, or down... the answer the next morning was down. The answer was down, but after flushing out to $20 it bounced right back to $22, where we took the[More...]

A New Index of Health Product Innovators

Mon, 05 Jan 2009 01:03:00 GMT

The accompanying table includes statistics and all 23 companies in the ETF Innovators (ETFI) Global Health Innovators Index of companies with market caps over $250M which received FDA approval in the past 12 months for an original new drug product or medical device. The index includes companies which get approvals for drugs or biological agents classified as new chemical entities (i.e. excluding all new formulations of existing drugs, generic drugs, and label extensions for[More...]

UPI NewsTrack Health and Science News

Thu, 30 Jul 2009 22:13:00 GMT

UPI NewsTrack Health and Science News[More...]

FTC tries to block device-maker's purchase

Thu, 30 Jul 2009 21:59:00 GMT

FTC tries to block device-maker's purchase[More...]

Market Woes Pull Down Local Stocks

Thu, 01 Jan 2009 14:16:00 GMT

Jan. 1--The investment meltdown of 2008 that plunged the financial markets into their worst year in seven decades also engulfed stocks throughout the Bay Area.
"It has to get better," said Richard Welty, president of Lafayette-based Welty Capital Management.
During the fourth quarter of 2008, a Bloomberg-compiled index of Bay Area public companies declined 25.4 percent, while a Bloomberg index of East Bay public companies fell 22.1 percent.

: iStockAnalyst.com Symbols Feed

FDA Calendar Updates: MELA, PGNX, VPHM, WYE, NeurogesX, Thoratec

Thoratec (NasdaqGS: THOR) Executing Well In The Healthcare Space

Sequenom (Nasdaq: SQNM) Bombshell

RVs Losing Speed

FDA, Clinical Trial Calendar Updates: THOR, ALTH

Thoratec (THOR) Beats; Market Yawns

Green names in a Sea of Red

A New Global Healthcare Composite Index

Playbook For The Week

A New Index of Health Product Innovators

UPI NewsTrack Health and Science News

FTC tries to block device-maker's purchase

Market Woes Pull Down Local Stocks

Market Woes Pull Down Local Stocks

Hammered

East Bay Stocks Top Region and Nation

Thoratec Presentation at Canaccord Adams Conference to Be Webcast

Thoratec Reports 20 Percent Growth in Second Quarter Cardiovascular Division Revenues As Overall Sales Increase 11 Percent

Thoratec Corporation and HeartWare International, Inc. Announce Termination of Proposed Transaction

Thoratec Schedules Second Quarter Conference Call, Webcast

U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International

Bulova Technologies Group Inc. Announces Significant New Contract Awards to Subsidiary BT Manufacturing

SmallCapSentinel.com Releases Report for Investors of Medical Device Companies SENO, STXS, EVVV, ANGO, THOR, and CPTS

Thoratec Announces Appointment of Paul LaViolette to Board of Directors

Thoratec Presentation at JMP Securities Conference to be Webcast

Thoratec Reports 39 Percent Increase in Quarterly Revenues as Cardiovascular Division Revenues Increase 61 Percent

Form 4 COLE J DANIEL For: Oct 06 (10K)

Form 4 THORATEC CORP For: Sep 16 Filed by: Cohen Lawrence (10K)

Form 4 COLE J DANIEL For: Aug 11 (10K)

Form 4 GROSSMAN D KEITH For: Aug 07 (10K)

Form 4 GROSSMAN D KEITH For: May 13 (10K)

Form 4 FINNEY ELISHA W For: May 13 (10K)

Form 4 MULVENA DANIEL M For: May 13 (10K)

Form 4 DIMICK NEIL F For: May 13 (10K)

Form 4 COLLIS STEVEN H For: May 13 (10K)

Form 4 COLE J DANIEL For: May 13 (10K)